Teva (TEVA -1.4%) makes a few management changes to its executive leadership team, appointing...
Monday, November 5, 2012, 10:20 AM ETTeva (TEVA -1.4%) makes a few management changes to its executive leadership team, appointing SVP Allan Oberman to President and CEO of Teva Americas Generics, replacing current chief executive William Marth who will step down and retire at the end of 2013. The company also promotes Jill DeSimone to the newly created position of SVP and General Manager of Teva Global Women’s Health franchise. Ms. DeSimone is a seasoned veteran in specialty medicine franchising, and will manage all aspects of building the business.
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles